Can I Buy AbbVie Inc Shares in India?

Yes, AbbVie Inc shares can be bought in India by opening an international trading account with Groww.

How to Buy AbbVie Inc Shares in India?

One can easily invest in AbbVie Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy AbbVie Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of AbbVie Inc.

What is the Share Price of AbbVie Inc?

The share price of AbbVie Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current AbbVie Inc share price is $173.50 as of 12 Dec ‘24

What is the Market Cap of AbbVie Inc?

The AbbVie Inc market cap is $306.05B as of 12 Dec ‘24

What is the PE and PB ratio of AbbVie Inc?

The PE and PB ratio of AbbVie Inc is 59.8 and 50.7 as of 12 Dec ‘24

AbbVie Inc Share Price, ABBV Stock Price Quote Today

<img alt="AbbVie Inc" srcSet="https://assets-netstorage.groww.in/intl-stocks/logos/ABBV.png 1x, https://assets-netstorage.groww.in/intl-stocks/logos/ABBV.png 2x" src="https://assets-netstorage.groww.in/intl-stocks/logos/ABBV.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
AbbVie Inc Healthcare 
$173.50
+0.31(0.18%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$174.91$173.193,4697,050,291
FundamentalsMarket Cap$306.05B
P/B Ratio50.7
P/E Ratio59.8
Enterprise Value$369.87B
Div. Yield3.79%
Book Value6.84
EPS(TTM)1.00
ROENA
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyAbbVie is a relatively new biopharmaceutical company established in 2013; prior to that, it had been under Abbott Laboratories, sharing its legacy and rich history. Within just a few years AbbVie Inc. has established a stronghold over the scientific industry. 
Based in Chicago, Illinois, it markets its products in the entire United States, Germany, France, Italy, Canada, Japan, Spain, Brazil, the United Kingdom and the Netherlands. AbbVie focuses on providing patients with transformational medicines and therapies that would benefit and improve their lives. 
It aims to discover more than just a cure for the numerous severe diseases rampant across the world. Taking up new challenges is the principal vision of AbbVie and it has employed about 47,000 individuals across the globe in its search of difficult-to-cure illnesses. In 2020, it actively partook to find the vaccine to combat the Covid-19 pandemic. It donated an amount of $35 million to aid Covid-19 relief across the world. 
Its contribution to the development of its community and the global society, in general, has been recognised by esteemed directories like DiversityInc Top 50 Companies for Philanthropy, Dow Jones Sustainability World Index, The Civic 50.
AbbVie Inc. entered the American stock market around the same time it was formed, with an initial stock price of $34.40. The company witnessed its highest-ever stock price on 26th January 2018, when it reached $123.21. 
It develops medications and therapies for some of the most difficult to deal with diseases and physical ailments. Few of its world-renowned products include its biological therapies, medical inhibitors, medicine for treating adults with leukaemia or lymphoma, medication for respiratory diseases, pancreatic enzyme therapy, and an array of treatments for rare and critical illnesses. Few of its most notable products include Humira, Skyrizi, Rinvoq, etc. The global sales of Ibrutinib, one of AbbVie’s most noted products, was estimated to be worth approximately $5 billion in 2020 – reaching 5 times more than the estimated amount in 2016, contributing to the company’s performance in terms of revenue generation.;
OrganisationAbbVie Inc
IndustryDrug Manufacturers—General
HeadQuartersNorth Chicago, IL
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$174.91	$173.19	3,469	7,050,291

Market Cap	$306.05B
P/B Ratio	50.7
P/E Ratio	59.8
Enterprise Value	$369.87B

Organisation	AbbVie Inc
Industry	Drug Manufacturers—General
HeadQuarters	North Chicago, IL